T0	Participants 325 391	subjects who participated in the Prostate Cancer Prevention Trial.
T1	Participants 444 534	317 prostate cancer cases and 353 controls, nested in the Prostate Cancer Prevention Trial
T2	Participants 864 921	in subjects who were treated with finasteride for 3 years